You are here

Glycobac, LLC

Company Information
Address
1938 Harney Street
Laramie, WY 82072-3037
United States


http://glycobac.com/

Information

UEI: JCN3NV7P5FD8

# of Employees: 1


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Insect cell lines for glycoprotein structural biology and mannose-dependent protein drugs

    Amount: $224,597.00

    Project Summary / AbstractThe objective of the proposed research is to create and validate new insect cell lines that can be used to produce glycoproteins (proteins with attached sugars to their surfa ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  2. Engineering a new insect cell line for human-type protein glycosylation

    Amount: $217,385.00

    Abstract The global market for `biologicsandaposwhich are new generation drugs produced using genetically engineered biological systemsis projected to reach $billion byOne system currently being used ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  3. Glycoengineered insect cells for commercial biologics manufacturing

    Amount: $939,580.00

    DESCRIPTION provided by applicant Therapeutic proteins or andapos biologicsandapos represent a andgt $ billion market that includes a variety of important drugs such as antibodies and hormone ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  4. Glycoengineered baculoviruses for the production of more efficacious influenza va

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): Vaccination significantly reduces morbidity and mortality caused by annual influenza epidemics. Traditionally, influenza vaccines have been manufactured using adap ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  5. Engineering cells for concurrent protein drug biosynthesis and polysialylation

    Amount: $148,202.00

    Project Summary / Abstract Therapeutic proteins, or biologics, represent a 100 billion market that includes drugs such as antibodies, hormones, and many others. The clinical efficacy of biologics is ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  6. A Novel Adherence Technology for Ophthalmic Medications

    Amount: $599,241.00

    DESCRIPTION: Most human therapeutic glycoproteins (biologics) are manufactured using mammalian cell lines that can add the human-type glycans required for their clinical efficacy. However, mammalian ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government